CTFG
BIIB icon

Capstone Triton Financial Group’s Biogen BIIB Stock Holding History

Capstone Triton Financial Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-75
Closed -$18K – 142
2020
Q4 		$18K Buy
+75
New +$19.3K 0.01% 289

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capstone Triton Financial Group's BIIB Position: Q1 2021 in Review

Capstone Triton Financial Group sold out of Biogen (BIIB) in Q1 2021, closing a stake of 75 shares — an estimated $18K sold.

Capstone Triton Financial Group first reported a position in BIIB in Q4 2020 and held it in 1 quarter. The position peaked at $18K in Q4 2020. 1,093 funds tracked by Wall St. Rank hold BIIB as of Q1 2021.

  • Capstone Triton Financial Group reported no remaining Biogen position as of Q1 2021 after selling out during the quarter.
  • Capstone Triton Financial Group sold 75 Biogen shares in Q1 2021, an estimated $18K.
  • Capstone Triton Financial Group first reported a position in Biogen in Q4 2020 and held it in 1 quarter.
  • Capstone Triton Financial Group's Biogen position peaked at $18K in Q4 2020.
  • 1,093 funds tracked by Wall St. Rank held Biogen as of Q1 2021.

Based on Capstone Triton Financial Group's 13F filing for Q1 2021, filed 17 May 2021.